With a solid foundation in MES and IT service management, I have been instrumental in advancing digitalisation within Novo Nordisk CMC, ensuring compliance with GxP standards to drive operational excellence. Leveraging deep expertise in MES and ITIL principles, I enable seamless integration of IT operations with manufacturing objectives, supporting Novo Nordisk’s broader digital transformation strategy.
My role focuses on defining and maintaining MES architecture aligned with CMC’s business goals, leading the MES deployment roadmap, and providing architectural oversight throughout project planning and execution. I design scalable MES solutions that integrate with ERP and DCS, translating complex business needs into robust, compliant solutions. By gathering and aligning requirements with operational workflows, I ensure MES enhancements adopt emerging technologies for future readiness.
The Pop in Your Job: What drives me is the opportunity to shape the future of pharma manufacturing through digital innovation. I love working at the crossroads of technology and operations, where MES solutions transform complexity into efficiency and compliance. Leading architecture and deployment strategies allows me to design systems that not only meet today’s needs but anticipate tomorrow’s challenges.
The real reward comes from seeing these solutions empower teams and accelerate Novo Nordisk’s digitalization journey. Every project is a chance to push boundaries, adopt emerging technologies, and deliver measurable impact. Knowing that my work contributes to safer, smarter, and more sustainable manufacturing is what makes this role truly exciting.
Case Study
Monday, March 23
11:00 am - 11:25 am
Live in Everett
Less Details
This session will focus on the pivotal role of the end-user experience in successful Manufacturing Execution System (MES) implementations. We will examine how involving end users from the design phase through to execution can significantly enhance system adoption, minimize deviations, and boost operational efficiency. By drawing on best practices from Novo Nordisk CMC Operations, we will showcase how user-friendly solutions can streamline workflows and save valuable time. Additionally, we will highlight the importance of engaging Line of Business and IT/OT teams to emphasize system functionality and ensure effective training throughout the implementation process. In this session, you will learn:
Panel Discussion
Monday, March 23
06:45 pm - 07:15 pm
Live in Everett
Less Details
The use of new technologies (AI, High-throughput screening) in drug discovery has created an unprecedented backlog of drug candidates in parallel to the increasing importance and success of biologics. The pressure to bring medicines to the patient faster increases the need to accelerate R&D and make tech transfer to manufacturing more efficient. The pressure to bring these innovative medicines to patients more quickly has intensified the need to streamline research and development (R&D) processes and improve the efficiency of technology transfer to manufacturing. Companies must focus on enabling faster and more efficient scale-ups from the pre-clinical phase through clinical trials and into commercial manufacturing. How do we harness the technologies available today to speed up product commercialization through Tech Transfer into Manufacturing? Key areas for discussion will include the following: